Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

246 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A miRNA screening identifies miR-192-5p as associated with response to azacitidine and lenalidomide therapy in myelodysplastic syndromes.
Mongiorgi S, De Stefano A, Ratti S, Indio V, Astolfi A, Casalin I, Pellagatti A, Paolini S, Parisi S, Cavo M, Pession A, McCubrey JA, Suh PG, Manzoli L, Boultwood J, Finelli C, Cocco L, Follo MY. Mongiorgi S, et al. Among authors: boultwood j. Clin Epigenetics. 2023 Feb 20;15(1):27. doi: 10.1186/s13148-023-01441-9. Clin Epigenetics. 2023. PMID: 36803590 Free PMC article.
Clonality in the myelodysplastic syndromes.
Boultwood J, Wainscoat JS. Boultwood J, et al. Int J Hematol. 2001 Jun;73(4):411-415. doi: 10.1007/BF02994002. Int J Hematol. 2001. PMID: 11503954 Review.
Gene expression profiling in the myelodysplastic syndromes using cDNA microarray technology.
Pellagatti A, Esoof N, Watkins F, Langford CF, Vetrie D, Campbell LJ, Fidler C, Cavenagh JD, Eagleton H, Gordon P, Woodcock B, Pushkaran B, Kwan M, Wainscoat JS, Boultwood J. Pellagatti A, et al. Among authors: boultwood j. Br J Haematol. 2004 Jun;125(5):576-83. doi: 10.1111/j.1365-2141.2004.04958.x. Br J Haematol. 2004. PMID: 15147372 Free article.
Gene expression profiling in the myelodysplastic syndromes.
Pellagatti A, Fidler C, Wainscoat JS, Boultwood J. Pellagatti A, et al. Among authors: boultwood j. Hematology. 2005 Aug;10(4):281-7. doi: 10.1080/10245330500065680. Hematology. 2005. PMID: 16085540 Free article. Review.
Gene expression profiles of CD34+ cells in myelodysplastic syndromes: involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.
Pellagatti A, Cazzola M, Giagounidis AA, Malcovati L, Porta MG, Killick S, Campbell LJ, Wang L, Langford CF, Fidler C, Oscier D, Aul C, Wainscoat JS, Boultwood J. Pellagatti A, et al. Among authors: boultwood j. Blood. 2006 Jul 1;108(1):337-45. doi: 10.1182/blood-2005-12-4769. Epub 2006 Mar 9. Blood. 2006. PMID: 16527891 Free article.
Lenalidomide inhibits the malignant clone and up-regulates the SPARC gene mapping to the commonly deleted region in 5q- syndrome patients.
Pellagatti A, Jädersten M, Forsblom AM, Cattan H, Christensson B, Emanuelsson EK, Merup M, Nilsson L, Samuelsson J, Sander B, Wainscoat JS, Boultwood J, Hellström-Lindberg E. Pellagatti A, et al. Among authors: boultwood j. Proc Natl Acad Sci U S A. 2007 Jul 3;104(27):11406-11. doi: 10.1073/pnas.0610477104. Epub 2007 Jun 18. Proc Natl Acad Sci U S A. 2007. PMID: 17576924 Free PMC article.
Gene expression profiling of CD34+ cells in patients with the 5q- syndrome.
Boultwood J, Pellagatti A, Cattan H, Lawrie CH, Giagounidis A, Malcovati L, Della Porta MG, Jädersten M, Killick S, Fidler C, Cazzola M, Hellström-Lindberg E, Wainscoat JS. Boultwood J, et al. Br J Haematol. 2007 Nov;139(4):578-89. doi: 10.1111/j.1365-2141.2007.06833.x. Epub 2007 Oct 3. Br J Haematol. 2007. PMID: 17916100 Free article.
246 results